TaiwanJ Pharmaceuticals Co., Ltd. (TPEX:6549)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
7.68
-0.02 (-0.26%)
At close: Mar 10, 2026
-19.92%
Market Cap 615.34M
Revenue (ttm) n/a
Net Income (ttm) -25.36M
Shares Out 80.12M
EPS (ttm) -0.32
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 29,873
Average Volume 87,726
Open 7.80
Previous Close 7.70
Day's Range 7.49 - 7.84
52-Week Range 6.99 - 10.60
Beta -1.54
RSI 42.44
Earnings Date Mar 24, 2026

About TaiwanJ Pharmaceuticals

TaiwanJ Pharmaceuticals Co., Ltd., a specialty pharmaceutical company, develops and commercializes small molecules for chronic organ inflammation of metabolic, autoimmune, and infectious etiologies in Taiwan. The company develops JKB-122 and JKB-121; and novel chemical entities for therapy to address chronic liver diseases and allergy/asthma. Its products target various diseases that include liver inflammation/liver fibrosis, non-alcoholic steatohepatitis, non-alcoholic fatty liver disease, autoimmune diseases, asthma, and atopic dermatitis. Th... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2011
Employees 13
Stock Exchange Taipei Exchange
Ticker Symbol 6549
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.